TVTX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Travere Therapeutics (TVTX) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

TVTX is expected to report earnings to fall 9.06% to -63 cents per share on March 03

Travere Therapeutics TVTX Stock Earnings Reports

Q4'24

Est.

$-0.64

Q3'24

Missed

by $0.03

Q2'24

Beat

by $0.14

Q1'24

Beat

by $2.43

Q4'23

Beat

by $2.12

The last earnings report on October 31 showed earnings per share of -69 cents, missing the estimate of -66 cents. With 3.70M shares outstanding, the current market capitalization sits at 1.50B.

View a ticker or compare two or three

Compare

TVTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For TVTX
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for TVTX (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a biopharmaceutical company, which develops pharmaceutical products

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

3611 Valley Centre Drive

Phone

+1 888 969-7879

Employees

380

Web

https://www.travere.com